These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35944462)

  • 1. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma.
    Yang SC; Wang WY; Zhou JJ; Wu L; Zhang MJ; Yang QC; Deng WW; Sun ZJ
    Int Immunopharmacol; 2022 Oct; 111():109113. PubMed ID: 35944462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma.
    Liu J; Lin WP; Xiao Y; Yang QC; Bushabu Fidele N; Yu HJ; Sun ZJ
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111128. PubMed ID: 37907049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
    Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
    Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
    Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
    Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient.
    Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H
    J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis.
    Zi M; Xingyu C; Yang C; Xiaodong S; Shixian L; Shicheng W
    Apoptosis; 2023 Apr; 28(3-4):348-361. PubMed ID: 36370260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of promoter methylation and DNA methyltransferase-1 in the regulation of EpCAM expression in oral squamous cell carcinoma.
    Shiah SG; Chang LC; Tai KY; Lee GH; Wu CW; Shieh YS
    Oral Oncol; 2009 Jan; 45(1):e1-8. PubMed ID: 18485790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma.
    Sasaya T; Kubo T; Murata K; Mizue Y; Sasaki K; Yanagawa J; Imagawa M; Kato H; Tsukahara T; Kanaseki T; Tamura Y; Miyazaki A; Hirohashi Y; Torigoe T
    Cancer Med; 2023 Feb; 12(4):4605-4615. PubMed ID: 36200687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epigenetics in OSCC: an understanding above genetics.
    Vatsa PP; Jindal Y; Bhadwalkar J; Chamoli A; Upadhyay V; Mandoli A
    Med Oncol; 2023 Mar; 40(4):122. PubMed ID: 36941511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers.
    Wu T; Tang C; Tao R; Yong X; Jiang Q; Feng C
    Front Immunol; 2021; 12():693881. PubMed ID: 34552581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.
    Bhol CS; Mishra SR; Patil S; Sahu SK; Kirtana R; Manna S; Shanmugam MK; Sethi G; Patra SK; Bhutia SK
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166428. PubMed ID: 35533906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mucoadhesive celecoxib-loaded cubosomal sponges: Anticancer potential and regulation of myeloid-derived suppressor cells in oral squamous cell carcinoma.
    Mabrouk AA; El-Mezayen NS; Tadros MI; El-Gazayerly ON; El-Refaie WM
    Eur J Pharm Biopharm; 2023 Jan; 182():62-80. PubMed ID: 36513316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma.
    Kouketsu A; Haruka S; Kuroda K; Hitoshi M; Kensuke Y; Tsuyoshi S; Takahashi T; Hiroyuki K
    J Oral Pathol Med; 2023 Jan; 52(1):9-19. PubMed ID: 36380437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma.
    Hsieh YP; Chen KC; Chen MY; Huang LY; Su AY; Chiang WF; Huang WT; Huang TT
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
    Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
    Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.